Long-term study show the nine-valent HPV vaccine greatly reduces the risk of HPV infection and HPV-associated diseases Cervical cancer is the second most common cause of cancer-related death... Read more
Immunotherapy is a treatment option that uses a person’s own immune system to fight cancer Moffitt Cancer Center has initiated a phase I clinical trial for a new immunotherapy drug, ID-G305,... Read more
There is a need to develop therapeutic vaccines for HPV-related tumors Researchers at Moffitt Cancer Center have developed and tested in mice a synthetic vaccine and found it effective in ki... Read more